Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Rashid A Barnawi, Rahaf Z Attar, Sultan S Alfaer & Osama Y Safdar. (2018) Is the light at the end of the tunnel nigh? A review of ADPKD focusing on the burden of disease and tolvaptan as a new treatment. International Journal of Nephrology and Renovascular Disease 11, pages 53-67.
Read now
Read now
Articles from other publishers (15)
Gyuyeong Rah, Hwayeon Cha, Joohee Kim, Jieun Song, Hyunho Kim, Yun Kyu Oh, Curie Ahn, Minyong Kang, Jongmin Kim, Kyung Hyun Yoo, Min Jung Kim, Hyuk Wan Ko, Je Yeong Ko & Jong Hoon Park. (2022) KLC3 Regulates Ciliary Trafficking and Cyst Progression in CILK1 Deficiency–Related Polycystic Kidney Disease. Journal of the American Society of Nephrology 33:9, pages 1726-1741.
Crossref
Crossref
Martin Cloutier, Ameur M. Manceur, Annie Guerin, Myrlene Sanon Aigbogun, Dorothee Oberdhan & Marjolaine Gauthier-Loiselle. (2020) The societal economic burden of autosomal dominant polycystic kidney disease in the United States. BMC Health Services Research 20:1.
Crossref
Crossref
Vikas Gupta, Poonam Mehta, Ajay Kumar, Manoj Chaudhary, Subhash Chandra Diyundi, Prabodh K. Sehajpal, Kumarasamy Thangaraj & Singh Rajender. (2020) c.29C>T polymorphism in the TGF-β1 gene correlates with increased risk of End Stage Renal Disease: original study and meta-analysis. Meta Gene 25, pages 100703.
Crossref
Crossref
Svenja Koslowski, Camille Latapy, Pierrïck Auvray, Marc Blondel & Laurent Meijer. (2020) An Overview of In Vivo and In Vitro Models for Autosomal Dominant Polycystic Kidney Disease: A Journey from 3D-Cysts to Mini-Pigs. International Journal of Molecular Sciences 21:12, pages 4537.
Crossref
Crossref
Sarah Elshahat, Paul Cockwell, Alexander P. Maxwell, Matthew Griffin, Timothy O’Brien & Ciaran O’Neill. (2020) The impact of chronic kidney disease on developed countries from a health economics perspective: A systematic scoping review. PLOS ONE 15:3, pages e0230512.
Crossref
Crossref
Rebecca V. Walker, Jennifer L. Keynton, Daniel T. Grimes, Vrinda Sreekumar, Debbie J. Williams, Chris Esapa, Dongsheng Wu, Martin M. Knight & Dominic P. Norris. (2019) Ciliary exclusion of Polycystin-2 promotes kidney cystogenesis in an autosomal dominant polycystic kidney disease model. Nature Communications 10:1.
Crossref
Crossref
Asmin Andries, Kristien Daenen, François Jouret, Bert Bammens, Djalila Mekahli & Ann Van Schepdael. (2018) Oxidative stress in autosomal dominant polycystic kidney disease: player and/or early predictor for disease progression?. Pediatric Nephrology 34:6, pages 993-1008.
Crossref
Crossref
Geraldo Bezerra da Silva Junior, Juliana Gomes Ramalho de Oliveira, Marcel Rodrigo Barros de Oliveira, Luiza Jane Eyre de Souza Vieira & Eduardo Rocha Dias. (2018) Global costs attributed to chronic kidney disease: a systematic review. Revista da Associação Médica Brasileira 64:12, pages 1108-1116.
Crossref
Crossref
Katelyn A. McKenzie, Mirelle El Ters, Vicente E. Torres, Peter C. Harris, Arlene B. Chapman, Michal Mrug, Frederic F. Rahbari-Oskoui, Kyongtae Ty Bae, Douglas P. Landsittel, William M. Bennett, Alan S. L. Yu & Jonathan D. Mahnken. (2018) Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohort. BMC Nephrology 19:1.
Crossref
Crossref
Daniel Eriksson, Linda Karlsson, Oskar Eklund, Hans Dieperink, Eero Honkanen, Jan Melin, Kristian Selvig & Johan Lundberg. (2017) Real-world costs of autosomal dominant polycystic kidney disease in the Nordics. BMC Health Services Research 17:1.
Crossref
Crossref
Lucia de Stephanis, Anna Bonon, Katia Varani, Giovanni Lanza, Roberta Gafà, Paolo Pinton, Monika Pema, Stefan Somlo, Alessandra Boletta & Gianluca Aguiari. (2016) Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells. Clinical and Experimental Nephrology 21:2, pages 203-211.
Crossref
Crossref
Wisit Cheungpasitporn, Charat Thongprayoon, Priya Vijayvargiya, Pimjai Anthanont & Stephen B. Erickson. (2016) The Risk for New-Onset Diabetes Mellitus after Kidney Transplantation in Patients with Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Meta-Analysis. Canadian Journal of Diabetes 40:6, pages 521-528.
Crossref
Crossref
Piergiorgio Messa, Carlo Maria Alfieri, Emanuele Montanari, Mariano Ferraresso & Roberta Cerutti. (2016) ADPKD: clinical issues before and after renal transplantation. Journal of Nephrology 29:6, pages 755-763.
Crossref
Crossref
Fedele Lasaponara. (2018) ADPKD and ESRD: Established Data and Still Open Questions. A Diagnostic-Therapeutic and Qol Upgrade. Giornale di Tecniche Nefrologiche e Dialitiche 28:1, pages 63-77.
Crossref
Crossref
Alwyn T Gomez, Bryce A Kiberd, J Patrick Royston, Talal Alfaadhel, Steven D Soroka, Brenda R Hemmelgarn & Karthik K Tennankore. (2015) Comorbidity Burden at Dialysis Initiation and Mortality: A Cohort Study. Canadian Journal of Kidney Health and Disease 2, pages 68.
Crossref
Crossref